[1]
|
J. S. Zhu, G. M. Halpern and K. Jones, “The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis Part I,” Journal of Alternative and Complementary Medicine, Vol. 4, 1998, pp. 289-303.
|
[2]
|
K. Nakamura, Y. Yamaguchi, S. Kagota, Y. M. Kwon, K. Shinozuka and M. Kunitomo, “Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice,” Japanese Journal of Pharmacology, Vol. 79, 1999, pp. 335-341.
|
[3]
|
K. Nakamura, N. Yoshikawa, Y. Yamaguchi, S. Kagota, K. Shinozuka and M. Kunitomo, “Antitumour effect of cordycepin (3’-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation,” Anticancer Research, Vol. 26, 2006, pp. 43-48.
|
[4]
|
Y. Yamaguchi, S. Kagota, J. Haginaka and M. Kunitomo, “Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke,” FEBS Letters, Vol. 512, 2002, pp. 218-222.
|
[5]
|
J. Chen, W. Zhang, T. Lu, J. Li, Y. Zheng and L. Kong, “Morphological and genetic characterization of a cultivated Cordyceps sinensis fungus and its polysaccharide component possessing antioxidant property in H22 tumor-bearing mice,” Life Sciences, Vol. 78, 2006, pp. 2742-2748.
|
[6]
|
N. Yoshikawa, S. Yamada, C. Takeuchi, S. Kagota, K. Shinozuka, M. Kunitomo and K. Nakamura, “Cordycepin (3’-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3β activation and cyclin D1 suppression,” Naunyn- Schmiedeberg’s Archives of Pharmacology, Vol. 377, 2008, pp. 591-595.
|